Increased interferon-γmRNA expression following alloincompatible myoblast transplantation is inhibited by FK506

Muscle and Nerve

Volumn 19, Issue 7, 1996, Pages 829-835

  Guérette, Benoît ^a   Tremblay, Geneviève ^a   Vilquin, Jean Thomas ^a   Asselin, Isabelle ^a   Gingras, Marc ^a   Roy, Raynald ^b   Tremblay, Jacques P ^a  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

Author keywords

FK506; IFN ; mouse; myoblast; transplantation

Indexed keywords

DYSTROPHIN; GAMMA INTERFERON; TACROLIMUS;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL TRANSPLANTATION; CELLULAR IMMUNITY; CONTROLLED STUDY; GENE EXPRESSION; GENETIC TRANSCRIPTION; GRAFT REJECTION; HUMORAL IMMUNITY; IMMUNOSUPPRESSIVE TREATMENT; ISOGRAFT; MOUSE; MYOBLAST; NONHUMAN; PRIORITY JOURNAL;

EID: 0029999198     PISSN: 0148639X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4598(199607)19:7<829::AID-MUS3>3.3.CO;2-V     Document Type: Article

References (26)

1. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chlorophorm extraction. Anal Biochem 1987;162:156-159.
2. Fitch FW, McKisic MD, Lancki DW, Gajewski TF: Differential regulation of murine T lymphocyte subsets. Annu Rev Immunol 1993;11:29-48.
3. Gajewski TF, Fitch FW: Anti-proliferative effect of INF-gamma in immune regulation: I. IFN-gamma inhibits the proliferation of Th2 but not Th1 murine HTL clones. J. Immunol 1988;140:4245-4252.
4. Goebels N, Michaelis D, Wekerle H, Hohlfeld R: Human myoblasts as antigen-presenting cells. J Immunol 1992;149:661-667.
5. Guérette B, Asselin I, Vilquin JT, Roy R, Tremblay JP: Lymphocyte infiltration following allo- and xenomyoblast transplantation in mdx mice. Muscle Nerve 1995;18:39-51.
6. Gussoni E, Pavlath GK, Lanctot AM, Sharma K, Miller RG, Steinman L, Blau HM: Normal dystrophin transcripts detected in DMD patients after myoblast transplantation. Nature 1992;356:435-438.
7. Huard J, Bouchard JP, Roy R, Malouin F, Dansereau G, Labrecque C, Albert N, Richards CL, Lemieux B, Tremblay JP: Human myoblast transplantation: Preliminary results of 4 cases. Muscle Nerve 1992;15:550-560.
8. Huard J, Tremblay G, Verreault S, Labrecque C, Tremblay JP: Utilization of an antibody specific for human dystrophin to follow myoblast transplantation in nude mice. Cell Transpl 1993;2:113-118.
9. Huard J, Verreault S, Roy R, Tremblay M, Tremblay JP: High efficiency of muscle regeneration after human myoblast clone transplantation in SCID mice. J Clin Invest 1994;93:586-599.
10. Karpati G, Pouliot Y, Zubrzycka-Gaan E, Carpenter S, Ray PN, Worton RG, Holl P: Dystrophin is expressed in mdx skeletal muscle fibers after normal myoblast implantation. Am J Pathol 1989;135:27-32.
11. Kinoshita I, Vilquin J-T, Guérette B, Asselin I, Roy R, Tremblay JP: Very efficient myoblast allotransplantation in mice under FK506 immunosuppression. Muscle Nerve 1994;17:1407-1415.
12. Koenig M, Hoffman EP, Bertelson CJ, Monaco AP, Feener C, Kunkel LM: Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected in normal and affected individuals. Cell 1987;50:509-517.
13. Koenig M, Kunkel LM, Monaco AP: The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein. Cell 1988;53:219-228.
14. Kunkel LM, Monaco AP, Middlisnorth W, Ochs HD: Specific cloning of DNA fragments absent from the DNA of a male patient with an X-chromosome deletion. Proc Natl Acad Sci USA 1985;82:4778-4782.
15. Law PK, Bertorini TE, Goodwin TG, Chen M, Fang Q, Li H-J, Kirby DS, Florendo JA, Herrod HG, Golden GS: Dystrophin production induced by myoblast transfer therapy in Duchenne muscular dystrophy. Lancet 1990;336:114-115.
16. Law PK, Goodwin TG, Li H-J, Chen M: Plausible structural/ functional/behavioral/biochemical transformations following myoblast transfer therapy. Adv Exp Med Biol 1990;280: 241-250.
17. Michaelis D, Goebels N, Hohlfeld R: Constitutive and cytokine-induced expression of human leukocyte antigens and cell adhesion molecules by human myotubes. Am J Pathol 1993;143:1142-1149.
18. Monaco AP, Nerve RL, Colleti-Feener C, Bertelson CJ, Kurnit DM, Kunkel LM: Isolation of candidate cDNAs for portions of the Duchenne muscular dystrophy gene. Nature 1986; 323:646-650.
19. Morgan CJ, Hernandez CJ, Ward JS, Orosz CG: Detection of cytokine mRNA in vivo by polymerase chain reaction. Transplantation 1993;56:437-443.
20. Morgan JE, Hoffman EP, Partridge TA: Normal myogenic cells from newborn mice restore normal histology to degenerating muscles of the mdx mouse. J Cell Biol 1990;111:2437-2449.
21. Partridge TA, Morgan JE, Coulton GR, Hoffman EP, Kunkel LM: Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblasts. Nature 1989;337:176-179.
22. Ray PN, Belfall B, Duff C, Logan C, Kean V, Thompson MW, Sylvester JE, Gorski JL, Schmickel RD, Worton RG: Cloning of the breakpoint of an X;21 translocation associated with Duchenne muscular dystrophy. Nature 1985;318: 672-675.
23. Roy R, Dansereau G, Tremblay JP, Belles-Isles M, Labrecque C, Bouchard JP: Major histocompatibility complex (MHC) antigens expression on human myoblasts. Transpl Proc 1991;23:799-801.
24. Scott MO, Sylvester JE, Heiman-Patterson T, Shi YJ, Fieles W, Stedman H, Burghes A, Ray P, Worton R, Fischbeck KH: Duchenne muscular dystrophy gene expression in normal and diseased human muscle. Science 1988;239:1418-1420.
25. Tremblay JP, Malouin F, Roy R, Huard J, Bouchard JP, Satoh A, Richards CL: Results of a triple blind clinical study of myoblast transplantations without immunosuppressive treatment in young boys with Duchenne muscular dystrophy. Cell Transpl 1993;2:99-112.
26. Worton RG, Duff C, Sylvester JE, Schmickel RD, Willard HF: Duchenne muscle dystrophy involving translocation of the dmd gene next to ribosomal RNA genes. Science 1984; 224:147-149.